Kawin Technology Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 617

Employees

  • Stock Symbol
  • 688687

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $2.40
  • (As of Thursday Closing)

Kawin Technology General Information

Description

Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kawin Technology Stock Performance

As of 12-Nov-2026, Kawin Technology’s stock price is $2.40. Its current market cap is $410M with 171M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.40 $2.42 $2.15 - $4.09 $410M 171M 2.88M -$0.02

Kawin Technology Financials Summary

As of 30-Sep-2026, Kawin Technology has a trailing 12-month revenue of $176M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 406,909 475,400 379,777 667,249
Revenue 175,511 183,663 171,459 199,580
EBITDA (348) 14,521 28,488 23,831
Net Income (2,907) 4,255 19,841 16,470
Total Assets 397,849 399,208 358,300 345,373
Total Debt 66,213 72,083 34,045 7,748
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kawin Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Patents

Kawin Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025091442-A1 Neuraminidase inhibitor and use thereof in influenza virus Inactive 03-Nov-2023
EP-4786595-A1 Sirna for inhibiting hepatitis b virus and use thereof Pending 28-Sep-2023
WO-2025067544-A1 Sirna for inhibiting hepatitis b virus and use thereof Inactive 28-Sep-2023
WO-2024149084-A1 Antibody of hepatitis b virus surface antigen and use thereof Inactive 15-Jan-2023
WO-2024103979-A1 Compound for inhibiting herpes virus Inactive 17-Nov-2022
To view Kawin Technology’s complete patent history, request access »

Kawin Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kawin Technology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Investments (2)

Kawin Technology’s most recent deal was a Early Stage VC with Sciwind Biosciences for . The deal was made on 11-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sciwind Biosciences 11-Jan-2019 Early Stage VC Drug Discovery
Ginkgo 03-Aug-2015 Secondary Transaction - Private Drug Discovery
To view Kawin Technology’s complete investments history, request access »

Kawin Technology ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Kawin Technology’s complete esg history, request access »

Kawin Technology FAQs

  • When was Kawin Technology founded?

    Kawin Technology was founded in 2008.

  • Where is Kawin Technology headquartered?

    Kawin Technology is headquartered in Beijing, China.

  • What is the size of Kawin Technology?

    Kawin Technology has 617 total employees.

  • What industry is Kawin Technology in?

    Kawin Technology’s primary industry is Pharmaceuticals.

  • Is Kawin Technology a private or public company?

    Kawin Technology is a Public company.

  • What is Kawin Technology’s stock symbol?

    The ticker symbol for Kawin Technology is 688687.

  • What is the current stock price of Kawin Technology?

    As of 12-Nov-2026 the stock price of Kawin Technology is $2.40.

  • What is the current market cap of Kawin Technology?

    The current market capitalization of Kawin Technology is $410M.

  • What is Kawin Technology’s current revenue?

    The trailing twelve month revenue for Kawin Technology is $176M.

  • What is Kawin Technology’s annual earnings per share (EPS)?

    Kawin Technology’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process